Antioxidant and Prooxidant Prenylflavonoids
J. Agric. Food Chem., Vol. 48, No. 9, 2000 3883
antioxidant protocols; Armstrong, D., Ed.; Humana Press:
Totowa, NJ , 1998; pp 377-387.
Cao, G.; Sofic, E.; Prior, R. L. Antioxidant and prooxidant
behavior of flavonoids: structure-activity relationships.
Free Radical Biol. Med. 1997, 22, 749-760.
Chan, T.; Galati, G.; O′Brien, P. J . Oxygen activation during
peroxidase catalysed metabolism of flavones or flavanones.
Chem.-Biol. Interact. 1999, 122, 15-25.
Cheng, Z.-J .; Kuo, S.-C.; Chan, S.-C.; Ko, F.-N.; Teng, C.-M.
Antioxidant properties of butein isolated from Dalbergia
odorifera. Biochim. Biophys. Acta 1998, 1392, 291-299.
Chung, B. H.; Segrest, J . P.; Ray, M. J .; Brunzell, J . D.;
Hokanson, J . E.; Krauss, R. M.; Beaudrie, K.; Cone, J . T.
Single vertical spin density gradient ultracentrifugation.
Methods Enzymol. 1986, 12, 181-209.
Constant, J . Alcohol, ischemic heart disease, and the French
paradox. Clin. Cardiol. 1997, 20, 420-424.
Diaz, M. N.; Frei, B.; Vita, J . A.; Keaney, J . F., J r. Antioxidants
and atherosclerotic heart disease. N. Engl. J . Med. 1997,
337, 408-416.
Esterbauer, H.; Gebicki, J .; Puhl, H.; J urgens, G. N. The role
of lipid peroxidation and antioxidants in oxidative modifica-
tions of LDL. Free Radical Biol. Med. 1992, 13, 341-390.
Frei, B.; Gaziano, J . M. Content of antioxidants, preformed
lipid hydroperoxides, and cholesterol as predictors of the
susceptibility of human LDL to metal ion-dependent and
-independent oxidation. J . Lipid Res. 1993, 34, 2135-2145.
Galati, G.; Chan, T.; Wu, B.; O’Brien, P. J . Glutathione-
dependent generation of reactive oxygen species by the
peroxidase-catalyzed redox cycling of flavonoids. Chem. Res.
Toxicol. 1999, 12, 521-525.
Giessauf, A.; Steiner, E.; Esterbauer, H. Early detection of
tryptophan residues of apolipoprotein B is a vitamin E-
independent process during copper-mediated oxidation of
LDL. Biochim. Biophys. Acta 1995, 1256, 221-232.
Halliwell, B.; Gutteridge, J . M. C. Role of free radicals and
catalytic metal ions in human disease: An overview.
Methods Enzymol. 1990, 186 (Part B), 1-85.
as prooxidants at 25 µM by increasing TBARS produc-
tion during exposure of LDL to Cu2+. This prooxidant
activity was not observed in chalcones and flavanones
with prenyl or geranyl groups, suggesting that these
substituents influence the redox potential of the phe-
noxyl radicals potentially formed during Cu2+-mediated
oxidation of LDL. The mechanistic role of prenyl and
geranyl groups in antagonizing the prooxidant action
of flavanones and other flavonoids with phenol B rings
merits further investigation.
The potential impact of the prenylated flavonoids
found in beer and hops, with respect to their antioxidant
properties, on human health is not known. It remains
to be investigated whether the prenylchalcones and
prenylflavanones are absorbed from the intestines and
are antioxidatively active in vivo or are metabolized to
products with different antioxidant properties than their
parent compounds. In vivo studies are needed to estab-
lish the potential health benefits of prenylflavonoids,
alone or in combination, found in alcoholic and nonal-
coholic beverages or in dietary supplements.
ABBREVIATIONS USED
CN, chalconaringenin; DH, dehydrocycloxanthohumol
hydrate; DPN, 6,8-diprenylnaringenin; DPX, 4′-O-5′-C-
diprenylxanthohumol; DX, dehydrocycloxanthohumol;
6GN, 6-geranylnaringenin; 8GN, 8-geranylnaringenin;
GS, genistein; IX, isoxanthohumol; MCN, 4′,6′-dimethoxy-
2′,4-dihydroxychalcone; MXN, 4′-O-methylxanthohumol;
NG, naringenin; 6PN, 6-prenylnaringenin; 8PN, 8-pre-
nylnaringenin; PX, 5′- prenylxanthohumol; QC, quer-
cetin; TG, 2′,4′,6′,4-tetrahydroxy-3′-C-geranylchalcone;
TOC, R-tocopherol; TP, 2′,4′,6′,4-tetrahydroxy-3′-C-pre-
nylchalcone (desmethylxanthohumol); TX, tetrahydrox-
anthohumol; XG, xanthogalenol; XN, xanthohumol.
Hertog, M. G. L.; Feskens, E. J . M.; Hollman, P. C. H.; Katan,
M. B.; Kromhout, D. Dietary antioxidant flavonoids and risk
of coronary heart disease: the Zutphen elderly study. Lancet
1993, 342, 1007-1011.
ACKNOWLEDGMENT
J ain, A. C.; Gupta, R. C.; Sarpal, P. D. Synthesis of lupinifolin,
di-O-methylxanthohumol and isoxanthohumol and related
compounds. Tetrahedron 1978, 34, 3563-3567.
We are grateful to Ms. Chelsea J ohnston, Mr. Robert
Grove, and Mr. Alan W. Taylor for technical support.
Keaney, J . F., J r.; Frei, B. Antioxidant protection of low-density
lipoprotein and its role in the prevention of atherosclerotic
vascular disease. In Natural Antioxidants in Human Health
and Disease; Frei, B., Ed.; Academic Press: San Diego, CA,
1994; pp 303-351.
Kontush, A.; Finckh, B.; Karten, B.; Kohischutter, A.; Beisie-
gel, U. Antioxidant and prooxidant activity of R-tocopherol
in human plasma and low density lipoprotein. J . Lipid Res.
1996, 37, 1436-1448.
Laughton, M. J .; Halliwell, B.; Evans, P. J .; Hoult, J . R. S.
Antioxidant and pro-oxidant actions of the plant phenolics
quercetin, gossypol and myricetin. Effects on lipid peroxi-
dation, hydroxyl radical generation and bleomycin-depend-
ent damage to DNA. Biochem. Pharmacol. 1989, 38, 2859-
2865.
Neuzil, J .; Thomas, S. R.; Stocker R. Requirement for, promo-
tion, or inhibition by alpha-tocopherol of radical-induced
initiation of plasma lipoprotein lipid peroxidation. Free
Radical Biol. Med. 1997, 22, 57-71.
Otero, P.; Viana, M.; Herrera, E.; Bonet, B. Antioxidant and
prooxidant effects of ascorbic acid, dehydroascorbic acid and
flavonoids on LDL oxidation submitted to different degrees
of oxidation. Free Radical Res. 1997, 27, 619-626.
Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the
French paradox for coronary heart disease. Lancet 1992,
339, 1523-1526.
Rodriguez, R. J .; Miranda, C. L.; Kingkeohoi, S.; Stevens, J .
F.; Deinzer, M. L.; Buhler, D. R. Antioxidant and antihepa-
totoxic activities of prenylated flavonoids from hops. Toxi-
cologist 1999, 48, 923.
LITERATURE CITED
Afanas’ev, I. B.; Dorozhko, A. I.; Brodskii, A. V.; Kostyuk, V.
A.; Potapovitch, A. I. Chelating and free radical scavenging
mechanisms of inhibitory action of rutin and quercetin in
lipid peroxidation. Biochem. Pharmacol. 1989, 38, 1763-
1769.
Anto, R. J .; Sukumaran, K.; Kuttan, G.; Rao, M. N. A.;
Subbaraju, V.; Kuttan, R. Anticancer and antioxidant activ-
ity of synthetic chalcones and related compounds. Cancer
Lett. 1995, 97, 33-37.
Bors, W.; Michel, C.; Stettmaier, K. Antioxidant effects of
flavonoids. BioFactors 1997, 6, 399-402.
Bowry, V. W.; Stocker, R. Tocopherol-mediated peroxidation.
The prooxidant effect of vitamin E on the radical-initiated
oxidation of human low-density lipoprotein. J . Am. Chem.
Soc. 1993, 115, 6029-6044.
Briviba, K.; Sies, H. Nonenzymatic antioxidant defense sys-
tems. In Natural Antioxidants in Human Health and
Disease; Frei, B., Ed.; Academic Press: San Diego, CA; 1994;
pp 107-128.
Brown, J . E.; Khodr, H.; Hider, R. C.; Rice-Evans, C. A.
Structural dependence of flavonoid interactions with Cu2+
ions: implications for the antioxidant properties. Biochem.
J . 1998, 330, 1173-1178.
Buege, J . A.; Aust, S. D. Microsomal lipid peroxidation.
Methods Enzymol. 1978, 52, 302-310.
Camejo, G.; Wallin, B.; Enojarvi, M. Analysis of oxidation and
antioxidants using microtiter plates. In Free radical and